Mucofortin (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucofortin, is a mucolytic agent presented as an oral dosage form for oral use. It helps to thin and clear thick mucus in respiratory conditions such as acute bronchitis, chronic bronchitis and COPD exacerbations. GNH USA supplies Mucofortin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine acts on thick respiratory secretions to improve clearance in several pulmonary disorders. Acute bronchitis: reduces mucus viscosity to facilitate expectoration. Chronic bronchitis: helps maintain airway patency by thinning secretions. COPD exacerbations: assists in clearing mucus plugs during flare‑ups.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Abdominal discomfort - Headache - Metallic taste

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction - Bronchospasm - Stevens‑Johnson syndrome or severe skin reactions - Hepatic dysfunction

When prescribing acetylcysteine, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: adjust use in severe renal impairment. - Monitor for bronchospasm: especially in asthmatic patients. - Avoid in known hypersensitivity: discontinue if reaction occurs. - Consider pregnancy status: weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from moisture.

Acetylcysteine can affect the activity of other medicines, requiring attention to potential interactions.

Major Interactions (Avoid): - Nitroprusside: may enhance hypotensive effect. - Activated charcoal: reduces acetylcysteine absorption if given concurrently. - Anticoagulants (e.g., warfarin): may increase bleeding risk.

Moderate Interactions (Monitor Closely): - Carbapenem antibiotics: may reduce mucolytic efficacy. - Inhaled bronchodilators: monitor for bronchospasm. - Other mucolytics: avoid duplication of therapy.